It would have been interesting to have sat in on the senior management meetings at Merck that thrashed out the Organon ...

Organon saw significant volatility last month with a 30% decline in its share price, coinciding with the company's announcement of decreased earnings and a reduction in its dividend payout.

Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of Organon & Co (Symbol: OGN) entered into oversold territory, hitting an RSI reading of 27.8 ...

Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com. THE COMPANY: Organon is a global healthcare company with a primary focus on improving the health of women.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...